Loading
Quiver Bioscience
Quiver Bioscience creates transformational medicines for patients with brain disorders. Utilizing human disease models and novel AI, the company aims to decode brain diseases and reimagine drug development. Quiver is technology-driven and focuses on uncovering new biology and novel therapeutic approaches. The company collaborates with various stakeholders to advance its mission of improving patient outcomes through innovative solutions.
Funding
Every round, secondary, debt facility or acquisition involving Quiver Bioscience that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—